Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease ...

We are pleased to announce that development of our renal and anti-inflammatory pipelines has progressed to value-building milestones that we ...

In this interview Prof. Dr. Kristina Kusche-Vihrog speaks about the nanomechanics of living cells and their implications for ...

Chechen warlord and Kremlin ally Ramzan Kadyrov has sparked a conflict with Moscow by holding unofficial talks with Middle ...

The first victim of a Winnipeg serial killer was finally given a name Wednesday — after two-plus years of being known only as Mashkode Bizhiki’ikwe (Buffalo Woman) — as police declared there is “no ...

Base editing corrected a mutation that causes macular degeneration, highlighting the potential of gene therapy to treat ...